BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11724970)

  • 1. Beta-arrestin and Mdm2, unsuspected partners in signaling from the cell surface.
    Strous GJ; Schantl JA
    Sci STKE; 2001 Nov; 2001(110):pe41. PubMed ID: 11724970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2.
    Wang P; Gao H; Ni Y; Wang B; Wu Y; Ji L; Qin L; Ma L; Pei G
    J Biol Chem; 2003 Feb; 278(8):6363-70. PubMed ID: 12488444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
    Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
    Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.
    Usui I; Imamura T; Huang J; Satoh H; Shenoy SK; Lefkowitz RJ; Hupfeld CJ; Olefsky JM
    Mol Cell Biol; 2004 Oct; 24(20):8929-37. PubMed ID: 15456867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
    Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
    J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2.
    Shenoy SK; Modi AS; Shukla AK; Xiao K; Berthouze M; Ahn S; Wilkinson KD; Miller WE; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6650-5. PubMed ID: 19363159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2.
    Salcedo A; Mayor F; Penela P
    EMBO J; 2006 Oct; 25(20):4752-62. PubMed ID: 17006543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase.
    Lin HK; Wang L; Hu YC; Altuwaijri S; Chang C
    EMBO J; 2002 Aug; 21(15):4037-48. PubMed ID: 12145204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination.
    Ahmed MR; Zhan X; Song X; Kook S; Gurevich VV; Gurevich EV
    Biochemistry; 2011 May; 50(18):3749-63. PubMed ID: 21466165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity.
    Hanson SM; Cleghorn WM; Francis DJ; Vishnivetskiy SA; Raman D; Song X; Nair KS; Slepak VZ; Klug CS; Gurevich VV
    J Mol Biol; 2007 Apr; 368(2):375-87. PubMed ID: 17359998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
    Bergamaschi D; Samuels Y; Zhong S; Lu X
    Oncogene; 2005 May; 24(23):3836-41. PubMed ID: 15782125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-arrestin signaling and regulation of transcription.
    Ma L; Pei G
    J Cell Sci; 2007 Jan; 120(Pt 2):213-8. PubMed ID: 17215450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2, an introduction.
    Iwakuma T; Lozano G
    Mol Cancer Res; 2003 Dec; 1(14):993-1000. PubMed ID: 14707282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of different mechanisms of arrestin-mediated signaling.
    Gurevich VV; Gurevich EV
    Curr Protoc Pharmacol; 2014 Dec; 67():2.10.1-2.10.9. PubMed ID: 25446289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior.
    Beaulieu JM; Sotnikova TD; Marion S; Lefkowitz RJ; Gainetdinov RR; Caron MG
    Cell; 2005 Jul; 122(2):261-73. PubMed ID: 16051150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-independent functions of MDM2.
    Ganguli G; Wasylyk B
    Mol Cancer Res; 2003 Dec; 1(14):1027-35. PubMed ID: 14707286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective increase in the association of the β2 adrenergic receptor, β Arrestin-1 and p53 with Mdm2 in the ventral hippocampus one month after underwater trauma.
    Sood R; Ritov G; Richter-Levin G; Barki-Harrington L
    Behav Brain Res; 2013 Mar; 240():26-8. PubMed ID: 23174211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.
    Honda R; Yasuda H
    Oncogene; 2000 Mar; 19(11):1473-6. PubMed ID: 10723139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of arrestins in intracellular signaling].
    Szymiczek M; Kurowska E; Gorczyca WA
    Postepy Hig Med Dosw (Online); 2005 Jul; 59():324-33. PubMed ID: 16012393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.